OR7E26P

Across TCGA pan-cancer cohorts, OR7E26P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of OR7E26P’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where OR7E26P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR7E26P is over-expressed in tumor, although a few such as BRCA and PRAD show the opposite, repressed pattern.

THCA, BRCA, and COAD are the cancer types where OR7E26P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR7E26P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	+0.141	<.001	7	view →
BRCA	All	All	−0.077	.001	4	view →
COAD	All	All	+0.072	.002	4	view →
UCEC	All	All	+0.195	.008	2	view →
PRAD	All	All	−0.061	.004	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

OR7E26P–THCA

Open the THCA breakdown →